The approach to sepsis by the emergency medical physician in a global setting can appear challenging at first however early recognition, resuscitation and stabilization and medication administration are the core principles within the core practice of emergency medicine
This powerpoint (ppt) presentation describes in details Pathophysiology and Management of Acute Sepsis in Emergency Department. Acute sepsis has 30% mortality and further more Septic Shock has 50% mortality if untreated. It is the job of Emergency Physician to recognise and treat Sepsis in time.
This lecture details the science of sepsis care in 2015 with compliments to the multiple online sources used, some of which are other lectures on SlideShare.
This powerpoint (ppt) presentation describes in details Pathophysiology and Management of Acute Sepsis in Emergency Department. Acute sepsis has 30% mortality and further more Septic Shock has 50% mortality if untreated. It is the job of Emergency Physician to recognise and treat Sepsis in time.
This lecture details the science of sepsis care in 2015 with compliments to the multiple online sources used, some of which are other lectures on SlideShare.
Sepsis is SIRS which is due to an infection
Sepsis is a major cause of mortality, killing approximately 1,400 people worldwide every day
Everyone has the potential to get sepsis
Easy to identify – we know what we’re looking for
Tools – observations scoring, clinical acumen, experience
Sepsis Screening Tool
Sepsis is SIRS which is due to an infection Sepsis is a major cause of mortality, killing approximately 1,400 people worldwide every day.
Surviving Sepsis Campaign (2008)
It is fluid which is present
in the pericardial cavity of
heart b/w parietal pericardium n visceral pericardium.
The pericardial cavity is a
potential space lined by
mesothelium of the visceral n parietal pericardium.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
1. Management of a child with sever
Sepsis and Septic Shock
Prof. Hamida Esahli
Head of PICU Elkhadra Hospital
Date: 12/09/2013
Event : World Sepsis Day in Libya
2. Title: This is the footer
Date: 13th September 2013
Slide no: 2
OBJECTIVE;
Identifying sepsis
•What do we look for in sepsis?
•Which patients get sepsis?
•What is sever sepsis?
•What is Septic Shock?
•What is Sepsis six?
3. Title: This is the footer
Date: 13th September 2013
Slide no: 3
SEPSIS
•Sepsis is one of the oldest and most elusive syndromes in
medicine.
•1.Hippocrates claimed that sepsis (σ ´ηψις) was the
process by which flesh rots, swamps generate foul airs, and
wounds fester. Galen later considered sepsis a laudable
event, necessary for wound healing.
•2 With the confirmation of germ theory by Semmelweis,
Pasteur, and others, sepsis was recast as a systemic
infection, often described as“bloodpoisoning,”and assumed
t be the result of the host's invasion by pathogenic
organisms that then spread in the bloodstream
4. Title: This is the footer
Date: 13th September 2013
Slide no: 4
Who are risk groups?
Old
Young
Ill
Infections
Malignancy
How many of your patients are
included?
Compromised organs
Immunocompromised
Post chemotherapy
Malnutrition
Invasive lines
5. Title: This is the footer
Date: 13th September 2013
Slide no: 5
The Pathogenesis of Sepsis
Response to Stimulus
•Inflammation
•Immunosuppression
•Coagulopathy
•Mitochondrial dysfunction
Infectious Agents
•Endotoxin/LPS
•Lipopeptides
•Lipoteichoic acid
•DNA
•Flagellin
Susceptible Host
•Co-morbidities
•Age
•Genetic polymorphisms
SEP
SIS
6. Title: This is the footer
Date: 13th September 2013
Slide no: 6
Infectious or no ninfecectious
insult
Systemic inflammatory response
(SIRS)
Miocrovascular:
Endothelial function
Micro emboli
Gut mucosa ischemia
Hemodynamic:
vasodilatation Myocardial
depression
Redistribution/Shunting
O2 hypoxia
Organs
Cell
Mitochondria
Cellular damage/apoptosis
MODS
CNS –CVS-Renal-Hepatic-pulmonary-Hematology
Basic Pathophsiology
7. Title: This is the footer
Date: 13th September 2013
Slide no: 7
Definitions
Infection
Inflammatory response to
microorganisms, or
Invasion of normally sterile
tissues
Systemic Inflammatory
Response Syndrome (SIRS)
Systemic response to a
variety of processes
Sepsis
Infection plus
2 SIRS criteria
Severe Sepsis
Sepsis
Organ dysfunction
Septic shock
Sepsis
Hypotension despite fluid
resuscitation
Bone RC et al. Chest. 1992;101:1644-55.
8. Title: This is the footer
Date: 13th September 2013
Slide no: 8
Step 1: Is SIRS present?
A systemic response to a nonspecific insult
Infection, trauma, surgery, massive transfusion, etc
Defined as 2 of the following:
• Temperature > 38.3 or < 36 0C
• Heart rate in infant<90>160pmb
• in child<70>150bpm
• Respiratory rate >2SD above age
• AVPU V, P or U
• White cells < 4 or > 12
• If not diabetic, blood sugar >140mg/dl/l
9. Title: This is the footer
Date: 13th September 2013
Slide no: 9
Step 1: Is SIRS present?
Why do we see SIRS??
Temperature: ‘Pyrogens’ raise body temperature. Later, temperature drops
as we lose excess heat
HR: To stop B.P falling, heart rate rises
RR: The body needs more oxygen in sepsis, and tissues produce
more acid. RR increases to help with both.
AVPU: As B.P and cardiac output fall later in sepsis, blood flow
to the brain reduces
White cells: Rise to combat infection. As they are used up, if bone
marrow is exhausted WCC falls
Blood sugar: Rises as part of our ‘stress response’
10. Title: This is the footer
Date: 13th September 2013
Slide no: 10
Bacteria
Virus
Fungi
Parasite
Infection SIRS
Sepsis
Pancreatitis
Trauma
Infection
Other
Severe
Sepsis
11. Title: This is the footer
Date: 13th September 2013
Slide no: 11
SIRS = Systemic Inflammatory Response Syndrome
SepsisSIRSInfection/
Trauma
Severe Sepsis
, et al. Chest 1992;101:1644, Opal SM, et al. Crit Care Med 2000;28:S81
SIRS with a presumed or
confirmed infectious
process
Step 3 what is sepsis?
12. Title: This is the footer
Date: 13th September 2013
Slide no: 12
• Sepsis with 1 sign of organ
failure
• Cardiovascular (refractory
hypotension)
• Renal
• Respiratory
• Hepatic
• Hematologic
• CNS
• Metabolic acidosis
SepsisSIRSInfection/
Trauma
Severe Sepsis
Bone et al. Chest 1992;101:1644; Wheeler and Bernard. N Engl J Med 1999;340:207
13. Title: This is the footer
Date: 13th September 2013
Slide no: 13
Step 4: what is Severe Sepsis?
Sepsis with organ dysfunction, including shock:
CNS: Acutely altered mental statusGCS<11
CVS: Syst <5th precentiaor mean <65 mmHg
Need for vasoactive drug to maintain BP
Unexplained metabolic acidosis: Base deicit>5mEq/L
Resp: Pao2/FiO2<300 OR Paco2>65mmHg OR>50%FiO2need
to maintain saturation>92%
Renal: Creatinine >2mg/dl
or UO <0.5 ml/kg/hr for 2 hrs
Hepatic: Bilirubin >4.0mg /dl ALT2 times upper limit for age
Bone marrow: Platelets <80,000mm3/l
Hypoperfusion: Lactate >above limits lab
Coagulopathy: INR>1.5 or aPTT >60secs
14. Title: This is the footer
Date: 13th September 2013
Slide no: 14
:Age specific upper and/lower limits of heart rate to define
tachycardia and bradycardia , respiratory rate, hypotension
Age group HR
Mean(range)
RR(breath/
min)
Systolic
BP,mmHg
Upto1
month
140[100-
190]
>60 <60mmHg
2months to 1
year
130[80-190] >50 <70mmHg
1-5 years 80[60-140] >40 <70+[2xage]
6-10 years 80[60-130] >30 <70+[2xage]
>10years 75[60-100] >30 <90
For heart rate lower values are approximately at 5th percentile and upper at 95
percentile for blood pressure, the heart rate values are at 5th percentile and for
respiratory rate the values are at95th percentile
15. Title: This is the footer
Date: 13th September 2013
Slide no: 15
What is Septic shock?
• Septic shock
• In a child with sepsis presence of : hypotension [ systolic BP< 70
mmHg in infant, <70+2 x age after 1 year of age ] or need for
vasoactive drug to maintain BP above fifth centile range
• or signs of hypoperfusion----any three of the following
• : decreased pulse volume [ weak or absent dorsalis pedis pulse] ,
• capillary refilling>2Sec
• , tachycardia heart rate as defined in [table] ,
• core [ rectal /oral ] to peripheral [skin –toe] temperature gap >3C ,
and
• urine output [<0.5ml/kg/h ] or sign of CVS dysfunction
16. Title: This is the footer
Date: 13th September 2013
Slide no: 16
Step 2: What counts as an infection?
RECOGNITATION: SCEERING FOR
INFECTION
i.e, if it sounds like an infection (history), or if
it looks like an infection (examination,
observations), then it probably is an infection!!
17. Title: This is the footer
Date: 13th September 2013
Slide no: 17
Step 2: What counts as an infection?
Pneumonia 50%
Urinary Tract infection
Meningitis
Endocarditis
Device related
Central line
Cannula
• Abdominal 25%
• Pain
• Diarrhoea
• Distension
• Urgent laparotomy
• Soft tissue/ musculoskeletal
• Cellulitis
• Septic arthritis
• Fasciitis
• Wound infection
18. Title: This is the footer
Date: 13th September 2013
Slide no: 18
• Sepsis (documented or suspected infection plus ≥1 of the following)
• General Variables
• Fever.>38.3C
• Hypothermia(Core temperature <36C
• Heart rate > more than two SD above normal value for age
• Tachypnea
• Altered mental status
• Significant edema or positive fluid balance (>20ml/kg over 24 hr)
• Hyperglycaemia( plasma > 140mg/dl) in the absence of diabetes
• Inflammatory variables
• Leukocytosis (WBC count >12,000 mm3)
• Leukopenia( WBC count< 4000m3)
• Normal WBC count with >10% immature form
• Plasma C-reactive >two SD above normal value
• Plasma procalcitonin > TWO SD above normal
Diagnostic Criteria for Sepsis, Severe Sepsis, and
Septic Shock.
19. Title: This is the footer
Date: 13th September 2013
Slide no: 19
• Hemodynamic Variables
• Arterial hypotension SBP< 5TH Percentile or mean<65 mmHg
• Organ dysfunction Variables
• Arterial hypoxemia (Pao2/Fio2< 300)
• Acute oliguria (urine output <0.5ml/kg/hr for at least 2 hrs despite adequate
fluid resuscitation
• Creartinine increase >0.5mg/dl
• Coagulation abnormalities(INR >1.5 or aPT T>60s)
• Ileus
• Thrombocytopenia( platelet count <80,000mm3)
• Hperbilirubinemia (plasma total bilirubin >4mg/dl)
• Tissue perfusion variables
• Hyperlactaemia
• Decreased capillary refill or mottling skin
• Flash capillary refill
• Bounding peripheral pulses Warm Shock
• Wide pulse pressure(DPP< 1/3 of SBP)
20. Title: This is the footer
Date: 13th September 2013
Slide no: 20
Causes of organ failure
•Reduced delivery of oxygen to the tissues
•In sepsis, caused by any or all of:
• Hypoxia
• Hypotension
• Low cardiac output
• Redistribution of blood flow
• Oedema- further for oxygen to travel to cells
• Small blood clots (microthrombi)
• Mitochondria don’t work effectively
We need to correct these with interventions... And FAST
21. Title: This is the footer
Date: 13th September 2013
Slide no: 21
Mortality increases with increasing
organ failure
Hebert et al. Chest 1993;104:230-5
22. Title: This is the footer
Date: 13th September 2013
Slide no: 22
•For first 12 hours, 1% mortality per 5 minute delay
•Funk and Kumar, Crit Care Clinics 2011; 53-76
23. Title: This is the footer
Date: 13th September 2013
Slide no: 23
Sepsis Management
Time
Early diagnosis
Antibiotic administration
Hemodynamic stabilization
EGDT( A more definitive resuscitation strategy involves goal
oriented manipulation of cardiac preload ,after load and
contractility to achieve a balance between systemic oxygen
delivery and O2 demand River et al described steps
during the critical “GLODIN HOURS” (first 6 hours)
2012 Surviving Sepsis Campaign guidelines
24. Title: This is the footer
Date: 13th September 2013
Slide no: 24
N Engl J Med, Vol .354,No 19 November 2011
EGDT
25. Title: This is the footer
Date: 13th September 2013
Slide no: 25
26. Title: This is the footer
Date: 13th September 2013
Slide no: 26
27. Title: This is the footer
Date: 13th September 2013
Slide no: 27
Pre and post-discharge
Hospitalization
24 hours
6 hours
Recognition
Resuscitation
Initial Management
Maintenance
Recovery
RESUSCITATION
PHASE
GOAL: Keep him
alive for 24
hours
INITIAL
MANAGEMENT
PHASE
GOAL: Let’s get
him better
MAINTENANCE
PHASE
GOAL: Don’t kill
him
28. Title: This is the footer
Date: 13th September 2013
Slide no: 28
SEPSIS RESUSCTATION BUNDLE
• TO BE COMPLETWITHIN 3HOURS :
• Measure lactate level
• Obtain blood cultures prior to administration of antibiotics
• Administer broad sepectrum antibiotics
• Administer 20ml/kg crystalloid
• TO BE COMPLETED WITHIN 6 HOURS
• Apply vasopressors to maintain BP > 5th percentile for age
• In the event of persistent arterial hypotension despite volume
resuscitation:
• - Measure central venous pressure CVP>8mmHg
• - Measure central venous oxygen saturation(Scvo2)>70%
• Remeasure lactate if initial was elevated
29. Title: This is the footer
Date: 13th September 2013
Slide no: 29
Goal-directed therapy hemodynamic
target in septic shock
• Capillary refill <2Sec
• Urine out put>1ml/kg/h
• Heart rate: age approporiate
• Arterial O2 Sat >95%
• ScvO2 >70%
• Difference in preductal and postductal O2 <5%
• MAP Age appropriate
30. Title: This is the footer
Date: 13th September 2013
Slide no: 30
MANAGEMENT
•Maintain or restore airway, oxygenation and ventilation{up
to 40% of CO is used for work of breathing}
•Maintain or restore circulation: normal perfusion and blood
pressure; maintain or restore threshold HR
•MONITORING
•Pulse oximeter, ECG, BP, Pulse pressure, DBP,
Temperature, urine output, glucose, ionized calcium
31. Title: This is the footer
Date: 13th September 2013
Slide no: 31
Airway
Breathing
Circulation
Disability
Exposure
Assessing any Critically Ill patient
32. Title: This is the footer
Date: 13th September 2013
Slide no: 32
Recognize decreased mental status and perfusion. Begin high
flow O2.Establish IV/IO access
• INTIAL RESUSCITATION
Push boluses of 20cc/kg isotonic saline up&over 40cc/kg then
3rd subsequent bolus 0.5g/kg 5% albumin until perfusion
improves or unless rales or hepatomegly develop.
Correct hypoglycaemia &hypocalcaemia . Begin antibiotics
• Shock not reversed: Fluid refractory shock Begin inotropes
0
min
15
min
33. Title: This is the footer
Date: 13th September 2013
Slide no: 33
becomes...
34. Title: This is the footer
Date: 13th September 2013
Slide no: 34
The Sepsis Six
1. Give high flow oxygen
2. IV fluid resuscitation
3. Give IV antibiotics
4. Take blood culture
5. Check haemoglobin and lactate
6. Accurate hourly urine output monitoring
may require catheter
... plus Critical Care support to complete EGDT
EARLY GOAL- DIRECTED THERAPY
Within one hour
35. Title: This is the footer
Date: 13th September 2013
Slide no: 35
Step 1: Oxygen
Oxygen delivery (DO2) is impaired
So, high flow oxygen maximises SaO2
‘Sats’ of 99% are better than 95% in sepsis!!
DO2 = CaO2 x CO
CaO2 = ([Hb] x SaO2)
36. Title: This is the footer
Date: 13th September 2013
Slide no: 36
Step 1: Is oxygen supply keeping up
with demand?
Central venous O2 saturation
Reflects oxygen extraction
by tissue, relative to
oxygen delivery
Lactate clearance
Reflects transition
from anaerobic to
aerobic metabolism
Oxygen delivery is determined by:
Hemoglobin
Cardiac output
Arterial oxygen saturation
37. Title: This is the footer
Date: 13th September 2013
Slide no: 37
HEART
ARTERIESVEINS
ORGANS
O2
O2
O2
O2
O2
O2
O2
O2
STEP 1: Make sure
the pump is full
(volume depletion)
38. Title: This is the footer
Date: 13th September 2013
Slide no: 38
Step 2: Fluids
Why?
To reduce organ dysfunction and multi-organ failure
• By optimising tissue oxygen delivery
• By increasing organ perfusion
39. Title: This is the footer
Date: 13th September 2013
Slide no: 39
Fluid resuscitation
In the first hour:
• Fluids improve Cardiac Output (CO)
• Better Cardiac Output gives
•Higher delivery of O2
•Higher MAP
• This will reduce organ injury
40. Title: This is the footer
Date: 13th September 2013
Slide no: 40
Improving organ perfusion
• Organs have their own resistance to blood flow
• Perfusion depends therefore on pressure as well as flow
• Mean arterial pressure (MAP) is the key
MAP = CO x SVR
Where SVR is Systemic Vascular Resistance
Goal MAP > 65 or Systolic > 5th percentile
MAP = Diastolic + (systolic-diastolic)
3
An improved cardiac output gives a higher MAP
41. Title: This is the footer
Date: 13th September 2013
Slide no: 41
The C in the ABCs:
Volume Resuscitation
Assess for Volume Depletion
•History
•Exam - Organ perfusion – skin, brain, kidneys
•Measure intravascular pressures – arterial, central venous
Administer a “Fluid Challenge”
•20ml/kg cry stolid over 5-10 minutes up to over
60ml/kg until perfusion improves
Normalization of the heart rate
•Capillary refill of < 2sec
•Well felt dorsalis pedis pulses with no
differential between peripheral and
central pulses
•Warm extremities
•Normal of systolic pressure and pulse
pressure
•Urine output> 1 ml/kg/hour
•Return to baseline mental status tone
and posture
•Normal range respiratory rate
42. Title: This is the footer
Date: 13th September 2013
Slide no: 42
HEART
ARTERIESVEINS
ORGANS
O2
O2
O2
O2
O2
O2
O2
O2
STEP 2: Make the train is on
a fast track (vascular tone)
STEP 1: Make sure
the pump is full
(volume depletion)
STEP 3: See if supply is
keeping up with demand
43. Title: This is the footer
Date: 13th September 2013
Slide no: 43
How to fluid resuscitate
Judicious fluid challenges
• Up to 60ml/kg in divided boluses (min. 20ml/kg in shock)
Reassess for effect after each challenge
• HR, BP, capillary refill, urine output, RR
In patients with cardiac disease
• Use smaller volumes
• More frequent assessment
• Early CVC
44. Title: This is the footer
Date: 13th September 2013
Slide no: 44
Before starting antibiotics, take at least one blood
culture:
• Percutaneously
• AND at least one from each vascular access device (if > 48 hrs)
Other cultures:
• Urine
• CSF
• Faeces
• Wound swabs
• Sputum
• other fluids from within cavities, e.g, intraperitoneal
Step 3: Blood Cultures
45. Title: This is the footer
Date: 13th September 2013
Slide no: 45
Within 6 hours source must be controlled
With cultures, consider:
Diagnostic imaging X ray
USS
CT
MRI
Discuss with radiologist/ surgeon if an enclosed
collection suspected
Step 3b: Source Control
46. Title: This is the footer
Date: 13th September 2013
Slide no: 46
Guidelines for obtaining cultures before
starting antibiotics
•Obtain two or more sets of BCs (both aerobic and anaerobic
bottles)
•One or more BCs should be Percutaneously
•One BC from each Vascular access device in place > 48hrs
•Culture other sites as clinically indicated (eg, urine, wound,
sputum, faecal, bronchial aspirate, CSF)
47. Title: This is the footer
Date: 13th September 2013
Slide no: 47
Start therapy as soon as possible and certainly in the first
hour...
...preferably after taking blood cultures!!
Choice should include one or more with activity against likely
pathogen
•Penetration of presumed source
•Guided by local pathogens
•Give broad spectrum till defined
Step 4: Give Antibiotics
48. Title: This is the footer
Date: 13th September 2013
Slide no: 48
• Antimicrobial regimen should be reassessed daily for potential de-
escalationto the most appropriate single therapy should be
performed as soon as the susceptibility profile is known .
• . Duration of therapy typically 7–10 days; longer courses may be
appropriate in patients who have a slow clinical response,
• Use of low procalcitonin levels or similar biomarkers to assist
the clinician in the discontinuation of empiric antibiotics in
patients who initially appeared septic, but have no subsequent
evidence of infection
• For patients with severe infections associated with respiratory failure
and septic shock, combination therapy with an extended spectrum
beta-lactam and either an aminoglycoside or a fluoroquinolone is for
P. aeruginosa bacteremia
• A combination of beta-lactam and macrolide for patients with septic
shock from bacteremic Streptococcus pneumoniae infections
51. Title: This is the footer
Date: 13th September 2013
Slide no: 51
High lactate identifies tissue hypoperfusion in
patients at risk who have a normal BP
‘Cryptic shock’
Gives an overview of current tissue oxygen delivery
The Goal
Lactate to improve
as resuscitation
progresses
Step 5: Measure lactate
52. Title: This is the footer
Date: 13th September 2013
Slide no: 52
Risk stratification by lactate
0
5
10
15
20
25
30
35
40
%inhospitalMortality
Lactate threshold
Low (0 - 2.0)
Intermediate ( 2.1 - 3.9)
Severe (>4.0)
Trzeciak, S et al , Acad Emerg Med; 13, 1150-1151.
53. Title: This is the footer
Date: 13th September 2013
Slide no: 53
STEP 6: Urine Output
Urine output is a direct measure of GFR
GFR= Glomerular Filtration Rate
GFR is directly proportional to CO
Kidneys receive 1/5 cardiac output (1 L/min)
CO falls UO falls
Therefore urine output in the early stages is a useful
assessment of cardiac output
54. Title: This is the footer
Date: 13th September 2013
Slide no: 54
55. Title: This is the footer
Date: 13th September 2013
Slide no: 55
Renal Blood Flow & Urine Output
In health, kidneys
autoregulate, so UO is
independent of BP over
a wide range
In sepsis, this is lost and
UO will fall as BP falls
56. Title: This is the footer
Date: 13th September 2013
Slide no: 56
Effects of fluid resuscitation
So…
Fluid resuscitation can improve
• Cardiac output (raises)
• Blood pressure (raises)
• Haematocrit (lowers)
… each of which will improve urine output
57. Title: This is the footer
Date: 13th September 2013
Slide no: 57
Goals for the first hour
Evidence of success:
•MAP >65mmHg
•Improving capillary refill
•Warming of extremities
•Urine output >1 ml/kg/hr
•Improving mental status
•Decreasing lactate
58. Title: This is the footer
Date: 13th September 2013
Slide no: 58
Pre and post-discharge
Hospitalization
24 hours
6 hours
Recognition
Resuscitation
Initial Management
Maintenance
Recovery
RESUSCITATION
PHASE
GOAL: Keep him
alive for 24
hours
INITIAL
MANAGEMENT
PHASE
GOAL: Let’s get
him better
MAINTENANCE
PHASE
GOAL: Don’t kill
him
59. Title: This is the footer
Date: 13th September 2013
Slide no: 59
INITIAL MANAGEMENT PHASE
GOAL: Let’s get him better
• Supportive care
• Identify organ failures
• Customize antibiotics based on
cultures/sensitivities
• Additional diagnostic testing
• Inotropes/Vasopressors/Vasodila
tors
• Corticosteroids
• Blood Products and plasma
Therapies
• Specific care
• Lung protective ventilation
• Conservative fluid management
• Sedation/Anlagesia/drug
Toxicities
• Glycemic control
• Deep Vein Thrombosis
Prophylaxis
• Stress Ulcer Prophylaxis
• Nutrition :enteral and iv glucose
60. Title: This is the footer
Date: 13th September 2013
Slide no: 60
Hydrocortisone Therapy
a child is at risk of absolute adrenal insufficiency or adrenal pituitary
axis failure (e.g., purpura fulminans, congenital adrenal hyperplasia,
prior recent steroid exposure, hypothalamic/pituitary abnormality)
and remains in shock despite epinephrine or norepinephrine
infusion,
• then hydrocortisone can be administered ideally after attaining a
blood sample for determination of baseline cortisol concentration.
Hydrocortisone may be administered as an intermittent
• or continuous infusion at a dosage which
• may range from 1–2 mg/kg/day for stress
• coverage to 50 mg/kg/day titrated to reverse the shock
61. Title: This is the footer
Date: 13th September 2013
Slide no: 61
Persistent Pulmonary Artery Hypertension
• Inhaled NO therapy is the treatment of choice for uncomplicated
PPHN However,
• metabolic alkalinization remains an important initial resuscitative
strategy during
• shock because PPHN can reverse when acidosis
• Milrinone or inamrinone may be added to improve heart function as
tolerated
• ECMO remains the therapy of choice for patients with refractory
• PPHN and sepsis
•New investigations:
• support use of inhaled iloprost (synthetic analog of prostacyclin) or
adenosine infusion as modes of therapy for PPHN
62. Title: This is the footer
Date: 13th September 2013
Slide no: 62
MAINTENANCE PHASE
GOAL: Don’t kill him
•Avoid nosocomial
complications
•Ventilator-induced lung
injury
•Get tubes and lines out
of him
•Clots and bleeding
•Avoid new infection
•Hand washing
•Semi-recumbent position
•Get tubes and lines out of
him
•Minimize transfusions
63. Title: This is the footer
Date: 13th September 2013
Slide no: 63
Long-term Cognitive Impairment and Functional Disability
Among Survivors of Severe Sepsis
• Compared 516 severe sepsis survivors with 4517 survivors of non-
sepsis hospitalization
• Prevalence of mod/severe cognitive impairment increased by 10.6%
after sepsis
• Severe sepsis associated with development of 1.5 new limitations in
ADLs
• 59% of sepsis survivors had worsened cognitive and/or physical
function Long-term Cognitive Impairment and Functional Disability
Among Survivors of Severe Sepsis
• Significantly worse than for non-sepsis hospitalizations
Iwashyna et al. JAMA 2010;304(16):1787-94
64. Title: This is the footer
Date: 13th September 2013
Slide no: 64
What is it?
•SIRS + Infection = Sepsis
•Sepsis + Organ Failure = Severe Sepsis
•Sepsis + Shock = Septic Shock
•Mortality increases with more organ failure
•GOLDEN HOURS definitive recognition and
treatment provide maximal benefit in term of outcome
65. Title: This is the footer
Date: 13th September 2013
Slide no: 65
Editor's Notes
Sepsis is one of the oldest and most elusive syndromes in medicine.Hippocrates claimed that sepsis (σ ´ηψις) was the process by which flesh rots,swamps generate foul airs, and wounds fester.Galen later considered sepsis a laudable event, necessary for wound healing.2 With the confirmation of germ theory by Semmelweis, Pasteur, and others, sepsis was recast as a systemic infection,often described as“bloodpoisoning,”and assumed t bethe resultof the host’sinvasion by pathogenic organisms that then spread in the bloodstream